Arcellx, Inc.   Report issue

For profit Phase 1
Founded: Gaithersburg MD United States (2015)

Organization Overview

First Clinical Trial
2019
NCT04155749
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Arcellx, Inc.